Skip to main content
Premium Trial:

Request an Annual Quote

PGx in a Microcosm

Michael Rugnetta has an article at Science Progress suggesting that NIH's genetic-based warfarin study will help determine the potential for personalized medicine. "Certainly the outcome could have enormous implications for personalized medicine, a new medical field where the results of genetic tests or other biomarker assessments are used to tailor drugs and treatments to individual patients," he writes. "Pharmacogemomics-based treatments ... need to pass the practicality test if biomedical innovation is to make a constructive contribution to a larger system-based healthcare infrastructure."

The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.